open access

Vol 28, No 2 (2021)
Editorial
Published online: 2021-03-24
Get Citation

Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome

Justyna Domienik-Karłowicz, Karolina Kupczyńska, Błażej Michalski, Agnieszka Kapłon-Cieślicka, Szymon Darocha, Piotr Dobrowolski, Maciej Wybraniec, Wojciech Wańha, Miłosz Jaguszewski
DOI: 10.5603/CJ.a2021.0036
·
Pubmed: 33843035
·
Cardiol J 2021;28(2):195-201.

open access

Vol 28, No 2 (2021)
Editorial
Published online: 2021-03-24

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome

Journal

Cardiology Journal

Issue

Vol 28, No 2 (2021)

Article type

Editorial

Pages

195-201

Published online

2021-03-24

DOI

10.5603/CJ.a2021.0036

Pubmed

33843035

Bibliographic record

Cardiol J 2021;28(2):195-201.

Authors

Justyna Domienik-Karłowicz
Karolina Kupczyńska
Błażej Michalski
Agnieszka Kapłon-Cieślicka
Szymon Darocha
Piotr Dobrowolski
Maciej Wybraniec
Wojciech Wańha
Miłosz Jaguszewski

References (29)
  1. Thygesen K. 'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018. Eur Heart J. 2019; 40(3): 226.
  2. Rittoo D, Jones A, Lecky B, et al. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction. J Am Coll Cardiol. 2014; 63(22): 2411–2420.
  3. Jaffe AS, Vasile VC, Milone M, et al. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011; 58(17): 1819–1824.
  4. Wens SCA, Schaaf GJ, Michels M, et al. Elevated plasma cardiac troponin T levels caused by skeletal muscle damage in pompe disease. Circ Cardiovasc Genet. 2016; 9(1): 6–13.
  5. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010; 31(18): 2197–2204.
  6. Thygesen K, Mair J, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012; 33(18): 2252–2257.
  7. Sarkisian L, Saaby L, Poulsen T, et al. Prognostic impact of myocardial injury related to various cardiac and noncardiac conditions. Am J Med. 2016; 129(5): 506–514.e1.
  8. Januzzi JL, Sandoval Y. The many faces of type 2 myocardial infarction. J Am Coll Cardiol. 2017; 70(13): 1569–1572.
  9. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2015; 37(3): 267–315.
  10. Jangaard N, Sarkisian L, Saaby L, et al. Incidence, frequency, and clinical characteristics of type 3 myocardial infarction in clinical practice. Am J Med. 2017; 130(7): 862.e9-862.e14.
  11. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007; 28(20): 2525–2538.
  12. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012; 33(20): 2551–2567.
  13. Rahimi K, Banning AP, Cheng ASH, et al. Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart. 2009; 95(23): 1937–1943.
  14. Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011; 154(8): 523–528.
  15. Devereaux PJ, Chan MTV, Alonso-Coello P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012; 307(21): 2295–2304.
  16. Kavsak PA, Walsh M, Srinathan S, et al. High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. Clin Biochem. 2011; 44(12): 1021–1024.
  17. Duvall WL, Sealove B, Pungoti C, et al. Angiographic investigation of the pathophysiology of perioperative myocardial infarction. Catheter Cardiovasc Interv. 2012; 80(5): 768–776.
  18. Agewall S, Beltrame JF, Reynolds HR, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017; 38(3): 143–153.
  19. Napp LC, Cammann VL, Jaguszewski M, et al. Coexistence and outcome of coronary artery disease in Takotsubo syndrome. Eur Heart J. 2020; 41(34): 3255–3268.
  20. Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015; 373(10): 929–938.
  21. Collet JP, Thiele H. Lesson learnt from the new 2020 ESC guidelines on non-ST-segment elevation acute coronary syndrome: when clinical judgement precedes and overpasses weak recommendations. 2020 non-ST-segment elevation acute coronary syndrome guidelines on pre-treatment: primum non nocere! Eur Heart J. 2020 [Epub ahead of print].
  22. Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020; 75(22): 2871–2872.
  23. Rodriguez-Leor O, Cid-Alvarez B. STEMI care during COVID-19: losing sight of the forest for the trees. JACC Case Rep. 2020; 2(10): 1625–1627.
  24. Holy EW, Jakob P, Manka R, et al. Impact of a nationwide COVID-19 lockdown on acute coronary syndrome referrals. Cardiol J. 2020; 27(5): 633–635.
  25. Wańha W, Wybraniec M, Kapłon-Cieślicka A, et al. Myocardial infarction in the shadow of COVID-19. Cardiol J. 2020; 27(5): 478–480.
  26. Legutko J, Niewiara Ł, Bartuś S, et al. Decline in the number of coronary angiography and percutaneous coronary intervention procedures in patients with acute myocardial infarction in Poland during the coronavirus disease 2019 pandemic. Kardiol Pol. 2020; 78(6): 574–576.
  27. Siudak Z, Grygier M, Wojakowski W, et al. Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions. Catheter Cardiovasc Interv. 2020; 96(6): E568–E575.
  28. Niccoli G, Luescher TF, Crea F. Decreased myocardial infarction admissions during COVID times: what can we learn? Cardiovasc Res. 2020; 116(10): e126–e128.
  29. Ibanez B, James S, Agewall S, et al. [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]. Kardiol Pol. 2018; 76(2): 229–313.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl